NDAINJECTIONINJECTABLEPriority Review
Approved
Sep 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Priority Review
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOTECT (dexrazoxane hydrochloride) is an injectable small molecule approved by the FDA in 2007 as a cardioprotective agent. It is indicated for the treatment of anthracycline extravasation, a serious complication of chemotherapy administration. The drug works by chelating iron and preventing free radical formation at the site of extravasation.
LOE Approaching
Product is in advanced lifecycle stage with LOE approaching; team size likely optimized and defensive.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Efficacy and Safety of Cytotect®CP, Hyperimmune Anti-CMV IVIg as CMV Prophylaxis in Patients Developing Acute Grade II-IV GVHD After Allogeneic Hematopoietic Cell Transplantation.
Started Sep 2022
2 enrolled
Cytomegalovirus Infections
Career Relevance
Working on TOTECT offers experience in specialty pharma marketing within a niche, high-acuity indication. However, the LOE-approaching lifecycle stage signals limited growth trajectory and smaller team investment; this role is best suited for professionals seeking stability and focused market expertise rather than rapid career expansion.
Brand Manager
Worked on TOTECT at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.